Work

388 A phase Ib trial in AD patients evaluating safety, tolerability, pharmacokinetics and efficacy of topical formulations containing the kappa-opioid receptor agonist WOL071-007

Year: 2018

Type: article

Source: Journal of Investigative Dermatology

DOI: 10.1016/j.jid.2018.03.395

Authors: M. Soeberdt, C. Masur, U. Knie, D. Metze, C. Abels

Institutions: Dr. August Wolff (Germany), University Hospital Münster

Language: English

Topic: Dermatology and Skin Diseases

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Therakos, Mallinckrodt Pharmaceuticals

OpenAlex ID: W2803073301

FWCI: 0.527

Cites:

Cited by: 2

Related to: 10